Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 33,800 | $0.00 Strike: $50.43 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 11 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,800 Underlying: Common stock, par value $0.001 · 33,800 shares Expires 2024-02-12 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 24,888 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 10 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Underlying: Common stock, par value $0.001 · 24,888 shares Expires 2027-02-23 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F12 · derivative.exercise_date: 20,679 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 59,404 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 9 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,404 Underlying: Common stock, par value $0.001 · 59,404 shares Expires 2026-02-24 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 19,153 | $0.00 Strike: $51.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 8 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,153 Underlying: Common stock, par value $0.001 · 19,153 shares Expires 2029-02-16 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F11 · derivative.exercise_date: These shares of the option will fully vest and become exercisable in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 18,539 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 7 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,539 Underlying: Common stock, par value $0.001 · 18,539 shares Expires 2028-02-21 F9 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 7,702 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantRestricted Stock Units · Derivative | 9,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 6 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,319 Underlying: Common stock, par value $0.001 · 9,319 shares Expires 2024-03-05 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F8 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on March 5, 2023 and March 5, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantRestricted Stock Units · Derivative | 7,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 5 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,237 Underlying: Common stock, par value $0.001 · 7,237 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantRestricted Stock Units · Derivative | 5,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 4 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,019 Underlying: Common stock, par value $0.001 · 5,019 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantRestricted Stock Units · Derivative | 2,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 3 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,722 Underlying: Common stock, par value $0.001 · 2,722 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantRestricted Stock Units · Derivative | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · derivative · entry 2 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 Underlying: Common stock, par value $0.001 · 3,930 shares Expires 2022-12-13 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on December 13, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Kambeyanda ShyamPresident and CEO
|
GrantCommon stock, par value $0.001 | 24,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023786 · doc4.xml · nonDerivative · entry 1 Kambeyanda Shyam · CIK 0001673243 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,102 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Teirlinck Didier PDirector
|
GrantStock Option (right to buy) · Derivative | 4,733 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001209191-22-023789 · doc4.xml · derivative · entry 4 Teirlinck Didier P · CIK 0001437676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 Underlying: Common stock, par value $0.001 · 4,733 shares Expires 2027-05-20 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Teirlinck Didier PDirector
|
GrantStock Option (right to buy) · Derivative | 5,567 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001209191-22-023789 · doc4.xml · derivative · entry 3 Teirlinck Didier P · CIK 0001437676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,567 Underlying: Common stock, par value $0.001 · 5,567 shares Expires 2026-05-13 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Teirlinck Didier PDirector
|
GrantStock Option (right to buy) · Derivative | 4,254 | $0.00 Strike: $40.55 | $0.00 |
DisclosureSEC source: 0001209191-22-023789 · doc4.xml · derivative · entry 2 Teirlinck Didier P · CIK 0001437676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 Underlying: Common stock, par value $0.001 · 4,254 shares Expires 2025-05-16 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Teirlinck Didier PDirector
|
GrantCommon stock, par value $0.001 | 8,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023789 · doc4.xml · nonDerivative · entry 1 Teirlinck Didier P · CIK 0001437676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,842 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 2,783 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 7 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783 Underlying: Common stock, par value $0.001 · 2,783 shares Expires 2026-05-13 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 2,127 | $0.00 Strike: $40.55 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 6 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,127 Underlying: Common stock, par value $0.001 · 2,127 shares Expires 2025-05-16 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 1,700 | $0.00 Strike: $49.42 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 5 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common stock, par value $0.001 · 1,700 shares Expires 2024-05-17 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 2,366 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 4 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,366 Underlying: Common stock, par value $0.001 · 2,366 shares Expires 2027-05-20 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 1,905 | $0.00 Strike: $31.10 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 3 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,905 Underlying: Common stock, par value $0.001 · 1,905 shares Expires 2023-05-12 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantStock Option (right to buy) · Derivative | 1,159 | $0.00 Strike: $63.37 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 2 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,159 Underlying: Common stock, par value $0.001 · 1,159 shares Expires 2022-05-12 F4 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. For Mr. Vinnakota, who, following the Spin-Off, will continue to serve as a director of Enovis (fka Colfax) and will serve as a director of ESAB, except for any shares or units deferred under the Colfax Director Deferred Compensation Plan, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:51 UTC |
Vinnakota RajivDirector
|
GrantRestricted Stock Units · Derivative | 1,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023791 · doc4.xml · derivative · entry 1 Vinnakota Rajiv · CIK 0001431876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321 Underlying: Common stock, par value $0.001 · 1,321 shares Expires 2022-05-12 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. For Mr. Vinnakota, 50% of his awards have been converted into ESAB equity awards and 50% will remain Colfax (Enovis) equity awards. F3 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on May 12, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:50 UTC |
Negro RenatoController, PAO
|
GrantRestricted Stock Units · Derivative | 3,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023788 · doc4.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,377 Underlying: Common stock, par value $0.001 · 3,377 shares Expires 2025-02-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:50 UTC |
Negro RenatoController, PAO
|
GrantRestricted Stock Units · Derivative | 5,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023788 · doc4.xml · derivative · entry 1 Negro Renato · CIK 0001624125 · Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,770 Underlying: Common stock, par value $0.001 · 5,770 shares Expires 2024-10-25 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F3 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on October 25, 2022. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 4,733 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 9 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 Underlying: Common stock, par value $0.001 · 4,733 shares Expires 2027-05-20 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 5,567 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 8 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,567 Underlying: Common stock, par value $0.001 · 5,567 shares Expires 2026-05-13 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 4,254 | $0.00 Strike: $40.55 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 7 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 Underlying: Common stock, par value $0.001 · 4,254 shares Expires 2025-05-16 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $49.42 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 6 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 Underlying: Common stock, par value $0.001 · 3,400 shares Expires 2024-05-17 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 3,810 | $0.00 Strike: $31.10 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 5 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,810 Underlying: Common stock, par value $0.001 · 3,810 shares Expires 2023-05-12 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantStock Option (right to buy) · Derivative | 2,318 | $0.00 Strike: $63.37 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · derivative · entry 4 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,318 Underlying: Common stock, par value $0.001 · 2,318 shares Expires 2022-05-12 F2 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantCommon stock, par value $0.001 | 266 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · nonDerivative · entry 3 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for spouse Disclosed balance after: 266 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantCommon stock, par value $0.001 | 2,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · nonDerivative · entry 2 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,063 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:48 UTC |
Jordan Rhonda LDirector
|
GrantCommon stock, par value $0.001 | 6,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023785 · doc4.xml · nonDerivative · entry 1 Jordan Rhonda L · CIK 0001359770 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust for family Disclosed balance after: 6,003 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Mlingo VusaSVP, Strategy & Business Dev.
|
GrantRestricted Stock Units · Derivative | 4,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023787 · doc4.xml · derivative · entry 2 Mlingo Vusa · CIK 0001910468 · SVP, Strategy & Business Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,954 Underlying: Common stock, par value $0.001 · 4,954 shares Expires 2025-02-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with a spin-off of ESAB from Colfax Corporation ("Colfax") (the "Spin-Off"), each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:49 UTC |
Mlingo VusaSVP, Strategy & Business Dev.
|
GrantRestricted Stock Units · Derivative | 9,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023787 · doc4.xml · derivative · entry 1 Mlingo Vusa · CIK 0001910468 · SVP, Strategy & Business Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761 Underlying: Common stock, par value $0.001 · 9,761 shares Expires 2025-01-10 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with a spin-off of ESAB from Colfax Corporation ("Colfax") (the "Spin-Off"), each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F3 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on January 10, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,044 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 12 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Underlying: Common stock, par value $0.001 · 5,044 shares Expires 2025-03-07 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,224 | $0.00 Strike: $50.43 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 11 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224 Underlying: Common stock, par value $0.001 · 4,224 shares Expires 2024-02-12 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 154 | $0.00 Strike: $63.37 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 10 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154 Underlying: Common stock, par value $0.001 · 154 shares Expires 2022-05-12 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,894 | $0.00 Strike: $55.96 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 9 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,894 Underlying: Common stock, par value $0.001 · 4,894 shares Expires 2028-02-21 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F10 · derivative.exercise_date: 2,034 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,570 | $0.00 Strike: $46.94 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 8 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,570 Underlying: Common stock, par value $0.001 · 6,570 shares Expires 2027-02-23 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. F9 · derivative.exercise_date: 5,459 shares of the option have already vested. The remaining shares of the option will fully vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,960 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 7 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,960 Underlying: Common stock, par value $0.001 · 3,960 shares Expires 2026-02-24 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 3,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 6 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,935 Underlying: Common stock, par value $0.001 · 3,935 shares Expires 2025-02-17 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F7 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 1,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 5 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324 Underlying: Common stock, par value $0.001 · 1,324 shares Expires 2024-02-22 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F6 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on February 22, 2023 and February 22, 2024. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 1,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 4 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Underlying: Common stock, par value $0.001 · 1,367 shares Expires 2023-07-25 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F5 · derivative.exercise_date: These restricted stock units vest and become exercisable in two equal installments on July 25, 2022 and July 25, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · derivative · entry 3 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718 Underlying: Common stock, par value $0.001 · 718 shares Expires 2023-02-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. F3 · kind: In connection with the Spin-Off, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest and become exercisable in a single installment on February 24, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantCommon stock, par value $0.001 | 351 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · nonDerivative · entry 2 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Plan Disclosed balance after: 351 Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:46 UTC |
Jewell Curtis ESVP, General Counsel
|
GrantCommon stock, par value $0.001 | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023783 · doc4.xml · nonDerivative · entry 1 Jewell Curtis E · CIK 0001910569 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397 F1 · balance_after: Shares acquired in the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB Corporation ("ESAB"). Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,044 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 11 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,044 Underlying: Common stock, par value $0.001 · 5,044 shares Expires 2025-03-07 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,582 | $0.00 Strike: $50.43 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 10 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,582 Underlying: Common stock, par value $0.001 · 3,582 shares Expires 2024-02-12 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:47 UTC |
Johnson Kevin JChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,199 | $0.00 Strike: $31.09 | $0.00 |
DisclosureSEC source: 0001209191-22-023784 · doc4.xml · derivative · entry 9 Johnson Kevin J · CIK 0001910487 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,199 Underlying: Common stock, par value $0.001 · 2,199 shares Expires 2023-02-14 F8 · kind: In connection with the Spin-Off, each outstanding Colfax stock option was converted into an award of options to purchase shares of ESAB common stock pursuant to the terms of the employee matters agreement between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax stock option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.